K Number
K212137
Device Name
X-Clever
Manufacturer
Date Cleared
2021-12-10

(155 days)

Product Code
Regulation Number
892.2050
Panel
RA
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Software used in a device that saves, enlarges, reduces, views as well as analyzes, transfers and prints medical images. (excluding fluoroscopic, angiographic, and mammographic applications.)

Device Description

LG Acquisition Workstation Software ASHK100G is a diagnostic software for final post-processed X-ray images of body parts of actual patients acquired through the integration of digital X-ray detectors (DXDs) and X-ray generators. By integrating the [MWL] and the [PACS] server, this software can be used to check the information and images of the patients' body parts in real time in a HIS (Hospital Information System) based environment.

A new image post-processing algorithm, MLP3 has been added to the proposed device. MLP3 provides image quality that is substantially equivalent to or slightly better than the predicate device even at lower x-ray dose levels. In addition, the functions have been added or modified to improve the user interface.

AI/ML Overview

The provided text describes the LG Acquisition Workstation Software ASHK100G (Model ASHK100G, Trade Name X-Clever), a medical image management and processing system. The main focus of the provided information regarding acceptance criteria and study proving device performance is on the MLP3 new image post-processing algorithm.

Here's an analysis of the provided text to extract the requested information:

1. A table of acceptance criteria and the reported device performance

The document doesn't explicitly state quantitative acceptance criteria in a pass/fail table format, but it does describe the performance goal for the MLP3 algorithm: to provide image quality "substantially equivalent to or slightly better than the predicate device even at lower x-ray dose levels" (for noise reduction) and "comparable to that of an image taken with an anti-scatter grid" (for scatter correction).

Acceptance Criteria (Implied)Reported Device Performance
MLP3 Noise Reduction Algorithm: Image quality of low dose images to be enhanced and comparable to standard dose images, with reduced radiation dose.Clinical Study Results (Adult Chest PA X-rays):
  • "The study showed that the image quality of adult chest PA x-rays taken at lower radiation doses and processed with our new image processing algorithm improved the overall diagnostic image quality, which became substantially equivalent to that of x-ray images acquired at standard dose levels."
  • "On average, radiation dose of images acquired at lower doses were approximately 50% less than that of images acquired at standard doses." |
    | MLP3 Scatter Correction Algorithm: Image quality of non-grid images to be enhanced and comparable to images taken with an anti-scatter grid, with reduced radiation dose/grid use. | Clinical Study Results (Adult Chest AP X-rays):
  • "The study showed that with our new algorithm, the image quality is improved for adult chest AP x-rays taken without an anti-scatter grid, and the improved image quality becomes comparable to images taken with an anti-scatter grid."
  • "On average, the radiation dose of non-grid images were 37% lower than that of grid images." |
    | Non-Clinical (In-house) Image Quality Evaluation (Adults): Image quality of MLP3 processed images to be equivalent to or slightly better than MLP2 (predicate). | Results: "The results show that our new image processing algorithm provides image quality equivalent to or slightly better than the predicate device." |
    | Non-Clinical (In-house) Image Quality Evaluation (Pediatric and Infant): Image quality of MLP3 processed phantom images to be equivalent to or slightly better than MLP2 (predicate). | Results: "The results show that our new image processing algorithm provides image quality equivalent to or slightly better than the predicate device." |

2. Sample sizes used for the test set and the data provenance

  • MLP3 Noise Reduction Algorithm Study:
    • Sample Size: Clinical images acquired from forty patients.
    • Data Provenance: "From one small clinical study performed at one clinical site," indicating prospective data collection from a single, likely domestic, location (Republic of Korea, based on applicant address). The study uses actual patient images.
  • MLP3 Scatter Correction Algorithm Study:
    • Sample Size: Clinical images acquired from forty patients.
    • Data Provenance: "From one small clinical study performed at one clinical site," indicating prospective data collection from a single, likely domestic, location (Republic of Korea). The study uses actual patient images.
  • In-house Image Quality Evaluation for Adults (Non-Clinical):
    • Sample Size: Clinical images of 30 common radiographic positions. (Note: this is positions, not necessarily distinct patients, though likely involves multiple patients).
    • Data Provenance: In-house bench testing results.
  • In-house Image Quality Evaluation for Pediatric and Infant (Non-Clinical):
    • Sample Size: Phantom testing results for a range of exams. Specific number of phantom images is not given, but refers to "chest, skull, abdomen and pelvis."
    • Data Provenance: In-house bench testing results.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

  • MLP3 Noise Reduction Algorithm Study:
    • Number of Experts: Three
    • Qualifications: "board certified radiologists."
  • MLP3 Scatter Correction Algorithm Study:
    • Number of Experts: Two
    • Qualifications: "board certified radiologists."

4. Adjudication method for the test set

The document does not explicitly state an adjudication method (e.g., 2+1, 3+1). It only says that the image qualities "were evaluated" by the radiologists. This implies that their opinions (or scores) were aggregated in some way, but the specific method for resolving inconsistencies or reaching a consensus is not detailed.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

The studies described were primarily focused on the algorithm's impact on image quality, which then allows for reduced dose or elimination of an anti-scatter grid while maintaining diagnostic image quality for human readers. These are not multi-reader multi-case (MRMC) comparative effectiveness studies designed to show how human readers directly improve their performance (e.g., accuracy, confidence) when assisted by AI vs. unassisted.

Instead, the studies show:

  • MLP3 (AI-powered post-processing) results in images from lower doses being "substantially equivalent" in diagnostic image quality to standard dose images.
  • MLP3 results in images without a grid being "comparable" in image quality to images with a grid.

The effect size is described in terms of dose reduction rather than human reader performance improvement:

  • Noise Reduction: "On average, radiation dose of images acquired at lower doses were approximately 50% less than that of images acquired at standard doses."
  • Scatter Correction: "On average, the radiation dose of non-grid images were 37% lower than that of grid images."

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

The primary evaluation of the MLP3 algorithm explicitly involved human readers (board-certified radiologists) evaluating the image quality. The "in-house image quality evaluation" (bench testing) also implies visual assessment of image quality, likely by human experts, to compare MLP3 and MLP2 output. Therefore, a purely "algorithm-only" performance metric independent of human assessment is not detailed as a primary outcome. The algorithm's function is to process images for human interpretation.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

The ground truth for the clinical studies appears to be expert evaluation/consensus of diagnostic image quality by board-certified radiologists. They assessed whether the processed images (low dose/no grid) were "substantially equivalent" or "comparable" in diagnostic quality to the higher dose/grid-obtained images. There is no mention of pathology or outcomes data as ground truth for this aspect of the device's performance.

8. The sample size for the training set

The document does not provide any information regarding the sample size for the training set used to develop or train the MLP3 algorithm. It only details the test sets.

9. How the ground truth for the training set was established

Since the document does not mention the training set size, it also does not provide information on how the ground truth for the training set was established.

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).